JPRN-UMIN000037176Not yet recruiting未知
Quantification of soluble-form signaling lymphocytic activation molecule family 7 (SLAMF7) and comprehensive gene expression analysis in serum samples among patients with relapsed/refractory multiple myeloma (RRMM): A multicenter prospective observational study (FBMTG RRMM18). - Quantification of SLAMF7 and comprehensive gene expression analysis in serum samples among patients with RRMM:(FBMTG RRMM18).
Fukuoka Blood and Marrow Transplant Group0 sites100 target enrollmentStarted: July 1, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Treated with >=4 lines of prior chemo-radiotherapy. 2. Diagnosed as solitary plasmacytoma, plasma cell leukemia, or POEMS syndrome. 3. Positive results of either HIV-antibody, HBs-antigen, or HCV-antibody(except for HCV-PCR negativity). 4. Uncontrolled following diseases:liver dysfunction, renal dysfunction, cardiac dysfunction, respiratory dysfunction, diabetes, hypertension, infection. 5. Active advanced double-cancer (concurrently existed or <=5 years of disease free period, excluding Carcinoma in situ at uterine cervix, stomach, or colon). 6. Severe mental disorders such as schizophremia. 7. Pregnant women, possible of pregnancy, or during lactation. 8. Judged as inappropriate to participate in this study by doctor.
Investigators
Similar Trials
Not yet recruiting
Unknown
se of soluble human leukocyte antigen as marker of embryo quality for clinical outcomes in women undergoing IVF/ICSI cyclesCTRI/2024/05/067437All India Institute of Medical Science
Not yet recruiting
Not Applicable
Correlation of specific type of white blood cells ratio during hospital admission in severity and outcome of acute stroke patientsCTRI/2021/08/035608Fortis Escorts Heart Institute
Recruiting
Not Applicable
A study using plasma samples obtained in the JACCRO GC-08 studyGastric CancerJPRN-UMIN000043051Japan Clinical Cancer Research Organization (JACCRO)501
Completed
Not Applicable
Marker of humoral and cellular immunity six to eight months after completing immunization against COVID-19 in residents of long-term care facilities for the elderlyCOVID-19U07.1COVID-19, virus identifiedDRKS00025813Institut für Medizinische Virologie, Universitätsklinikum Frankfurt426
Completed
Not Applicable
Expression of immune-related signal regulatory protein on peripheral blood mononuclear cells in non-small cell lung cancer patientsblood screeningPBMCsmall cell lung cancernon-small cell lung cancerlung cancerTCTR20190508003/A60